£

Mounjaro

 
We are currently out of stock of the 15mg doses due to the ongoing national supply issues with the 12.5mg and 15mg doses. We have a limited supply of 12.5mg which we are reserving for existing customers only. If you have ordered from us before, please contact us via email or WhatsApp to order your dose. Due to the shortage in stock, we will not be able to price match on the 12.5mg and 15mg doses.

 
Maximum Quantity Allowed:
2.5 mg
2.5mg + 5mg
5mg
7.5mg
7.5mg + 10mg
10mg
1 Pen
£

Mounjaro (tirzepatide) Injectable is a prescription medication licenced for weight loss and weight maintenance in adults. It has been used to manage blood sugar levels in adults with type 2 diabetes for many years. Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by enhancing insulin secretion, reducing glucagon levels, slowing digestion, and regulating appetite. It primarily works by regulating your appetite, giving you a sense of satiety (fullness). This combination helps improve blood sugar control and promotes weight loss. 

Fastest delivery:
Order by 12:00pm

  • GMC and GPhC-regulated clinicians

    Expert care from GMC and GPhC-regulated clinicians. Trust in professional medical advice and treatments tailored to your needs.

  • 100% UK-based pharmacy

    Our team of doctors and prescribers, and our support staff, are all UK-based.

  • Free support and advice

    We're on hand to offer free support and advice by email and telephone (Mon - Fri 08:30 - 17:00).

  • GP-Led Prescribing

    Expert care from GP-led clinicians. Receive professional, trusted medical advice and treatments tailored to your needs.

Description

Mounjaro (tirzepatide) Injectable is a prescription medication designed to manage blood sugar levels in adults with type 2 diabetes and aid in weight loss management. Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by enhancing insulin secretion, reducing glucagon levels, slowing digestion, and regulating appetite. This combination helps improve blood sugar control and promotes weight loss.

  • Dual-action for weight management: Targets two critical pathways (GIP and GLP-1) to improve blood sugar control.
  • Supports weight loss: Helps reduce appetite and increase feelings of fullness, making it easier to manage food intake. Reduces cravings.
  • Once-weekly injection: Convenient dosing helps maintain consistent management of blood sugar and weight.
  • Clinically proven: Demonstrated significant blood sugar and weight reductions in clinical trials, especially when combined with lifestyle changes.

Mounjaro is indicated for people with a BMI over 30 or a BMI over 27 with additional weight-related health concerns such as high blood pressure, diabetes, heart disease, high cholesterol or PCOS.

Warnings

  1. Do not use if you:

    • Are allergic to tirzepatide or any of the ingredients in Mounjaro.
    • Have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).
    • Are pregnant, planning to become pregnant, or breastfeeding.
  2. Consult a doctor before use if you:

    • Have a history of pancreatitis, gallbladder issues, or kidney disease.
    • Are taking other medications to manage blood sugar, such as insulin or sulfonylureas, as combining these with Mounjaro can increase the risk of hypoglycemia (low blood sugar).
    • Have gastrointestinal issues, as Mounjaro may cause digestive side effects.
  3. Discontinue use and seek medical attention if:

    • You experience severe stomach pain, nausea, or vomiting (possible signs of pancreatitis).
    • You notice swelling in your neck or throat or experience difficulty swallowing (potential signs of thyroid issues).
    • You develop gallbladder symptoms like pain in the upper right abdomen, fever, or jaundice.
  4. Not suitable for use in children: Mounjaro has not been studied in people under 18 years of age and is not approved for pediatric use.

  5. Keep out of reach of children: This is a prescription medication and should only be used by individuals for whom it is prescribed.

Directions

  1. Dosage:
    Mounjaro is administered as a once-weekly injection, with the starting dose typically at 2.5 mg. Your healthcare provider may gradually increase the dosage depending on your response to the medication and your treatment plan.

  2. Administration:
    Inject Mounjaro under the skin (subcutaneous injection) in the abdomen, thigh, or upper arm. Rotate injection sites to prevent irritation. Follow the instructions provided.

  3. Take with or without food:
    Mounjaro can be injected at any time of day, with or without meals. Ensure that you maintain a healthy diet and exercise routine for the best results.

  4. Do not exceed the prescribed dose:
    If you miss a dose, take it as soon as possible unless your next dose is due in less than 48 hours. Never double up on doses.

  5. Store properly:
    Store Mounjaro in the refrigerator until use. Once taken out of the fridge, it can be kept at room temperature for 30 days . 

Ingredients

Active Ingredient:

  • Tirzepatide (varied dosages starting at 2.5 mg): A dual GIP and GLP-1 receptor agonist that helps manage blood sugar and supports weight loss.

Inactive Ingredients:

  • Disodium phosphate dihydrate
  • Sodium chloride
  • Water for injections
  • Hydrochloric acid and/or sodium hydroxide (for pH adjustment)

These ingredients ensure the stability and proper delivery of the active compound.

Side Effects

Common Side Effects:

  1. Nausea: A common reaction, especially in the early stages of treatment.
  2. Diarrhea or constipation: Digestive upset is frequently reported but may improve over time.
  3. Vomiting: Can occur, particularly as the body adjusts to the medication.

Less Common but Serious Side Effects:

  1. Pancreatitis: Symptoms include severe abdominal pain, nausea, and vomiting. Seek immediate medical attention if these occur.
  2. Gallbladder problems: Pain in the upper right abdomen or jaundice could indicate gallstones or other gallbladder issues.
  3. Low blood sugar (hypoglycemia): Particularly if Mounjaro is used with other diabetes medications like insulin.

Rare Side Effects:

  1. Thyroid tumors: Report any neck swelling, difficulty swallowing, or hoarseness to your doctor.
  2. Kidney problems: Signs include reduced urine output and swelling in the hands and feet.
  3. Allergic reactions: Rash, itching, or swelling of the face or throat may indicate an allergic response.

FAQs

  • What comes with my pen?

         Each pen comes with needles and wipes and will provide 4 weekly doses.

  • What dose should we start with?
    The dose should be started low (2.5mg) and then increased every 4 weeks dependent on response. You can discuss your personalised plan with our clinical team at any time.

  • How does Mounjaro aid in weight loss?
    Mounjaro reduces appetite and slows digestion which increases the feeling of fullness, leading to a lower calorie intake. It regulates blood sugar levels and energy use to improve how the body processes food. When used alongside a healthy diet and exercise, it supports significant weight loss.

  • How is Mounjaro administered?
    Mounjaro is given as a once-weekly subcutaneous injection (under the skin). You can inject it in the abdomen, thigh, or upper arm. Inject aroud the same time each week. Always follow the instructions on the leaflet.

  • Are there any side effects?
    Common side effects include nausea, vomiting, diarrhea, stomach pain and constipation. Serious side effects, such as pancreatitis or gallbladder problems, are rare but possible. If you develop side-effects you can discuss your case with our clinical team to help your symptoms

  • How effective is Mounjaro?
    Mounjaro is one of the most effective weight loss treatments available. On average, people lose 20.9% body weight over 36 weeks and 25.3% body weight over 88 weeks. The active ingredient in Mounjaro was shown in a study to be twice as effective as Wegovy.